Project Details
| Status | Active |
|---|---|
| Effective start/end date | 7/24/13 → 7/23/38 |
Funding
- University of Michigan
A PHASE III TRIAL EVALUATING THE ADDITION OF TRASTUZUMAB TO TRIMODALITY TREATMENT OF HER2-OVEREXPRESSING ESOPHAGEAL ADENOCARCINOMA
- Butler, E. Brian (Project Director)
- Kim, Min Peter (Project Director)
- Teh, Bin S. (Project Director)
Project: Non Profit